Central therapeutic effects of peripheral vagus nerve stimulation

Academic Article


  • Despite the recent addition of more than ten new antiepileptic drugs on the market, epilepsy remains poorly controlled in almost 30% of patients. For this subgroup of patients with pharmacoresistant epilepsy, vagus nerve stimulation (VNS) has become a viable option. More recently, it has also shown promise in treatment-resistant depression. This article discusses VNS's history, current applications, and potential to treat chronic neurologic and psychiatric disorders. © ASET.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Gross M; Goyal M
  • Start Page

  • 47
  • End Page

  • 52
  • Volume

  • 47
  • Issue

  • 1